Mycobacterium tuberculosis uses sophisticated secretion systems, named 6 kDa early secretory antigenic target (ESAT6) protein family secretion (ESX) systems (also known as type VII secretion systems), to export a set of effector proteins that helps the pathogen to resist or evade the host immune response. Since the discovery of the esx loci during the M. tuberculosis H37Rv genome project, structural biology, cell biology and evolutionary analyses have advanced our knowledge of the function of these systems. In this Review, we highlight the intriguing roles that these studies have revealed for ESX systems in bacterial survival and pathogenicity during infection with M. tuberculosis. Furthermore, we discuss the diversity of ESX systems that has been described among mycobacteria and selected non-mycobacterial species. Finally, we consider how our knowledge of ESX systems might be applied to the development of novel strategies for the treatment and prevention of disease.
Mycobacterium tuberculosis (Mtb) uses efficient
strategies to evade the eradication by professional phagocytes, involving—as
recently confirmed—escape from phagosomal confinement. While
Mtb determinants, such as the ESX-1 type VII secretion system,
that contribute to this phenomenon are known, the host cell factors governing this
important biological process are yet unexplored. Using a newly developed
flow-cytometric approach for Mtb, we show that macrophages
expressing the phagosomal bivalent cation transporter Nramp-1, are much less
susceptible to phagosomal rupture. Together with results from the use of the
phagosome acidification inhibitor bafilomycin, we demonstrate that restriction of
phagosomal acidification is a prerequisite for mycobacterial phagosomal rupture and
cytosolic contact. Using different in vivo approaches including an
enrichment and screen for tracking rare infected phagocytes carrying the CD45.1
hematopoietic allelic marker, we here provide first and unique evidence of M.
tuberculosis-mediated phagosomal rupture in mouse spleen and lungs and in
numerous phagocyte types. Our results, linking the ability of restriction of
phagosome acidification to cytosolic access, provide an important conceptual advance
for our knowledge on host processes targeted by Mtb evasion
strategies.
Recent insights into the mechanisms by which Mycobacterium tuberculosis, the etiologic agent of human tuberculosis, is recognized by cytosolic nucleotide sensors have opened new avenues for rational vaccine design. The only licensed anti-tuberculosis vaccine, Mycobacterium bovis BCG, provides limited protection. A feature of BCG is the partial deletion of the ESX-1 type VII secretion system, which governs phagosomal rupture and cytosolic pattern recognition, key intracellular phenotypes linked to increased immune signaling. Here, by heterologously expressing the esx-1 region of Mycobacterium marinum in BCG, we engineered a low-virulence, ESX-1-proficient, recombinant BCG (BCG::ESX-1) that induces the cGas/STING/TBK1/IRF-3/type I interferon axis and enhances AIM2 and NLRP3 inflammasome activity, resulting in both higher proportions of CD8 T cell effectors against mycobacterial antigens shared with BCG and polyfunctional CD4 Th1 cells specific to ESX-1 antigens. Importantly, independent mouse vaccination models show that BCG::ESX-1 confers superior protection relative to parental BCG against challenges with highly virulent M. tuberculosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.